Koski Robert C's Form 4 filing
Oragenics Inc (OGEN) · filed Dec 16, 2022
- Accession no.
- 0001493152-22-035732
- Filed
- Dec 16, 2022, 4:05 PM ET
- Trade date
- Dec 14-15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $29.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Koski Robert CCIK 0001234880 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | Common Stock | SSaleDisposed | −25,000 | $0.175 | −$4,375 | 1,285,149 | Indirect | |
| Dec 15, 2022 | Common Stock | SSaleDisposed | −140,497 | $0.1758 | −$24,699.37 | 1,144,652 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.